Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001615774-18-005232

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rhodes John B Director 2018-06-12 Grant or award · Stock Option +30,000 30,000 D
Loading xslF345X03/s110812_form4.xml…